Drug intelligence / Profile preview

AL5300

Development stage
Unknown
Modality
Small Molecules
01

Overview

AL5300 is an experimental small molecule belonging to the thienothiazine class of organic compounds. Its chemical formula is C11H12N2O5S4 and it has a molecular weight of approximately 380.48 g/mol. The compound acts as an inhibitor of carbonic anhydrase 2 (CA-II), a zinc metalloenzyme involved in the reversible hydration of carbon dioxide and regulation of fluid secretion in various tissues. As a carbonic anhydrase inhibitor, AL5300 may have potential applications in diseases where modulation of CA-II activity is beneficial; however, there are currently no approved indications or active clinical trials for this compound[1][2][5]. It remains at the experimental stage with no evidence of progression beyond preclinical or early research phases.

Brand names
AL5300AL-5300AL 5300
Other names
3,4-dihydro-4-hydroxy-2-(2-thienylmethyl)-2H-thieno[3,2-e]-1,2-thiazine-6-sulfonamide-1,1-dioxide
02

Targets

CA2 (Carbonic Anhydrase 2)

Beyond the preview

Go deeper on AL5300.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on AL5300.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call